IP Library Assignment 068746/0913
Patent Assignment
Reel/Frame 068746/0913

Assignment of Assignor's Interest

Recorded: 2024-09-30 Pages: 17
Assignor
EIGER BIOPHARMACEUTICALS, INC.
Executed: 2024-09-03
Assignee
EIGER INNOTHERAPEUTICS, INC.
2061 WEBSTER STREET, PALO ALTO, CALIFORNIA, 94301
Covered Properties (23)
Treatment of Hepatitis Delta Virus Infection
Application: 15/335,327 →
Publication: US 2017/0042862
Pharmaceutical Compositions Comprising Lonafarnib and Ritonavir
Application: 15/567,444 →
Publication: US 2018/0110734
Treatment of Hepatitis Delta Virus Infection
Application: 16/052,386 →
Publication: US 2019/0167646
Treatment of Hepatitis Delta Virus Infection
Application: 16/996,147 →
Publication: US 2020/0375955
Methods of Treating Hepatitis Delta Virus Infection
Application: 17/073,920 →
Publication: US 2021/0093571
Treatment of Hepatitis Delta Virus Infection
Application: 17/655,470 →
Publication: US 2023/0046607
Methods to Treat Hepatitis Delta Viral Infections
Application: 17/754,587 →
Publication: US 2024/0082360
Pharmaceutical Compositions Comprising Lonafarnib and Ritonavir
Application: 17/969,005 →
Publication: US 2023/0218530
Treatment of Hepatitis Delta Virus Infection
Application: 18/467,858 →
Publication: US 2024/0277676
Treatment of Hepatitis Delta Virus with Lonafarnib
Application: 61/987,315 →
Treatment of Hepatitis Delta Virus with Lonafarnib
Application: 62/044,766 →
Treatment of Hepatitis Delta Virus with Lonafarnib
Application: 62/073,413 →
Pharmaceutical Compositions Comprising Lonafarnib and Ritanovir
Application: 62/150,721 →
Treatment of Hepatitis Delta Virus Infection
Application: 62/151,349 →
Pharmaceutical Compositions Comprising Lonafarnib and Ritanovir
Application: 62/153,815 →
Treatment of Hepatitis Delta Virus Infection
Application: 62/251,026 →
Treatment of Hepatitis Delta Virus Infection
Application: 62/297,740 →
Treatment of Hepatitis Delta Virus Infection
Application: 62/321,623 →
Methods to Treat Hepatitis Delta Viral Infections
Application: 62/915,933 →
Methods to Treat Hepatitis Delta Viral Infections
Application: 63/014,774 →
Methods to Treat Hepatitis Delta Viral Infections
Application: 63/070,047 →
Methods to Treat Hepatitis Delta Viral Infections
Application: 63/386,496 →
Methods to Treat Hepatitis Delta Viral Infections
Application: 63/386,661 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 4, 2014
From: CORY, DAVID; CHOONG, INGRID; GLENN, JEFFREY S.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 033672/0016 →
Assignment of Assignor's Interest Oct 30, 2014
From: CORY, DAVID; CHOONG, INGRID; GLENN, JEFFREY S.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 034075/0627 →
Assignment of Assignor's Interest Jan 27, 2015
From: CORY, DAVID; CHOONG, INGRID; GLENN, JEFFREY S
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 034823/0993 →
Assignment of Assignor's Interest Apr 27, 2015
From: CORY, DAVID; CHOONG, INGRID; GLENN, JEFFREY S.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 035500/0925 →
Assignment of Assignor's Interest Feb 17, 2016
From: CORY, DAVID; CHOONG, INGRID; GLENN, JEFFREY S.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 037758/0826 →
Assignment of Assignor's Interest Apr 7, 2016
From: CORY, DAVID A.; CHOONG, INGRID; GLENN, JEFFREY S.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 038223/0036 →
Assignment of Assignor's Interest Apr 15, 2016
From: GOSSELIN, PATRICK; BETANCOURT, AIMESTHER
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 038291/0565 →
Assignment of Assignor's Interest Aug 1, 2016
From: CORY, DAVID A.; CHOONG, INGRID; GLENN, JEFFREY S.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 039307/0730 →
Assignment of Assignor's Interest Dec 22, 2016
From: CORY, DAVID A.; CHOONG, INGRID; GLENN, JEFFREY S.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 040756/0213 →
Assignment of Assignor's Interest Feb 20, 2019
From: CORY, DAVID A.; CHOONG, INGRID; GLENN, JEFFREY S.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 048386/0997 →
Assignment of Assignor's Interest Nov 6, 2019
From: CHOONG, INGRID
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 050945/0364 →
Assignment of Assignor's Interest Jun 3, 2020
From: GOSSELIN, PATRICK; BETANCOURT, AIMESTHER
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 052825/0129 →
Assignment of Assignor's Interest Jun 25, 2020
From: CHOONG, INGRID; GLENN, JEFFREY
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 053038/0175 →
Assignment of Assignor's Interest Aug 18, 2020
From: CORY, DAVID A.; CHOONG, INGRID; GLENN, JEFFREY S.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 053525/0138 →
Assignment of Assignor's Interest Sep 11, 2020
From: CHOONG, INGRID; GLENN, JEFFREY
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 053750/0086 →
Assignment of Assignor's Interest Oct 21, 2020
From: GOSSELIN, PATRICK; BETANCOURT, AIMESTHER
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 054124/0182 →
Assignment of Assignor's Interest Mar 30, 2022
From: CORY, DAVID A.; CHOONG, INGRID; GLENN, JEFFREY S
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 059438/0266 →
Assignment of Assignor's Interest Apr 6, 2022
From: CHOONG, INGRID; GLENN, JEFFREY
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 059519/0053 →
Security Interest Jun 10, 2022
From: EIGER BIOPHARMACEUTICALS, INC.; EB PHARMA, LLC; EBPI MERGER, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 060156/0901 →
Assignment of Assignor's Interest Dec 12, 2022
From: CHOONG, INGRID; HISLOP, COLIN MICHAEL
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 062053/0918 →
Assignment of Assignor's Interest Dec 29, 2022
From: CHOONG, INGRID; HISLOP, COLIN MICHAEL
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 062232/0860 →
Assignment of Assignor's Interest Jul 17, 2023
From: GOSSELIN, PATRICK; BETANCOURT, AIMESTHER
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 064288/0009 →
Assignment of Assignor's Interest Sep 15, 2023
From: CORY, DAVID A.; CHOONG, INGRID; GLENN, JEFFREY S.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 064917/0390 →
Change of Name Sep 6, 2025
From: EIGER INNOTHERAPEUTICS, INC.
To: EIT PHARMA, INC.
Reel/Frame 072821/0334 →
Change of Name Dec 19, 2025
From: EIGER INNOTHERAPEUTICS, INC.
To: EIT PHARMA, INC.
Reel/Frame 073970/0913 →